Invention Grant
- Patent Title: Compositions and methods
-
Application No.: US15067469Application Date: 2016-03-11
-
Publication No.: US09750794B2Publication Date: 2017-09-05
- Inventor: James Brown , Pascal Mettens , Dennis Murphy
- Applicant: GlaxoSmithKline Biologicals, S.A.
- Applicant Address: BE GB
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA,GLAXO GROUP LIMITED
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA,GLAXO GROUP LIMITED
- Current Assignee Address: BE GB
- Agent Eric Kron
- Main IPC: A61K39/04
- IPC: A61K39/04 ; A61K39/00 ; A61K49/00 ; C07K14/35 ; C07H21/04
Abstract:
The present invention is directed to a polypeptide which comprises: (i) an Rv1753c protein sequence; (ii) a variant of an Rv1753c protein sequence; or (iii) an immunogenic fragment of an Rv1753c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.
Public/Granted literature
- US20160184420A1 Novel Compositions and Methods Public/Granted day:2016-06-30
Information query
